Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.
Lung neoplasms
sex
small cell lung cancer (SCLC)
smoking
symptoms
Journal
Translational lung cancer research
ISSN: 2218-6751
Titre abrégé: Transl Lung Cancer Res
Pays: China
ID NLM: 101646875
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
09
07
2021
accepted:
16
09
2021
entrez:
3
12
2021
pubmed:
4
12
2021
medline:
4
12
2021
Statut:
ppublish
Résumé
Lung cancer causes approximately 25% of all cancer deaths. Despite its relevance, few studies have analyzed differences by sex at the time of diagnosis in terms of symptoms, stage, age or smoking status. We aim to assess if there are differences between men and women on these characteristics at diagnosis. We analyzed the Thoracic Tumour Registry (TTR), sponsored by the Spanish Lung Cancer Group using a case-series design. This is a nationwide registry of lung cancer cases which started recruitment in 2016. For each case included, clinicians fulfilled an electronic record registering demographic data, symptoms, exposure to lung cancer risk factors, and treatment received in detail. We compared men and women using descriptive statistics. A total of 13,590 participants took part in this study, 25.6% women. Women were 4 years younger than men (64 There seems to be no differences in lung cancer characteristics by sex at the time at diagnosis on stage, specific symptoms or number of symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
Lung cancer causes approximately 25% of all cancer deaths. Despite its relevance, few studies have analyzed differences by sex at the time of diagnosis in terms of symptoms, stage, age or smoking status. We aim to assess if there are differences between men and women on these characteristics at diagnosis.
METHODS
METHODS
We analyzed the Thoracic Tumour Registry (TTR), sponsored by the Spanish Lung Cancer Group using a case-series design. This is a nationwide registry of lung cancer cases which started recruitment in 2016. For each case included, clinicians fulfilled an electronic record registering demographic data, symptoms, exposure to lung cancer risk factors, and treatment received in detail. We compared men and women using descriptive statistics.
RESULTS
RESULTS
A total of 13,590 participants took part in this study, 25.6% women. Women were 4 years younger than men (64
CONCLUSIONS
CONCLUSIONS
There seems to be no differences in lung cancer characteristics by sex at the time at diagnosis on stage, specific symptoms or number of symptoms.
Identifiants
pubmed: 34858780
doi: 10.21037/tlcr-21-559
pii: tlcr-10-10-3902
pmc: PMC8577975
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3902-3911Informations de copyright
2021 Translational Lung Cancer Research. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/tlcr-21-559). MP serves as an unpaid editorial board member of Translational Lung Cancer Research. MP and VCJ receive consulting fees from BMS, ROCHE, ASTRAZENECA, MSD, Boehringer. AE receives consulting fees from ROCHE, MSD, AstraZeneca. GB receives consulting fees from ROCHE, SANOFI. MG receives consulting fees from ROCHE, MSD, Bristol Myers. CAR receives consulting fees from ROCHE, MSD, BMS, AstraZeneca, Novartis, Pierre Fabre. ÓJ receives consulting fees from Boehringer, BMS, Merch, Roche, Astrazeneca, Lilly, Takeda. MD receives consulting fees from Astrazeneca, BMS, Boehriguer, MSD, Pfizer, Roche. JMT receives consulting fees from BMS, MSD, AstraZeneca, Boehringer. The other authors have no conflicts of interest to declare.
Références
Acta Oncol. 2017 Mar;56(3):448-454
pubmed: 27846762
ESMO Open. 2020 Nov;5(6):e001021
pubmed: 33214227
Am J Epidemiol. 2018 May 1;187(5):971-981
pubmed: 29087432
Ann Epidemiol. 2020 Jun;46:14-19
pubmed: 32532368
J Cancer Res Clin Oncol. 2020 May;146(5):1169-1196
pubmed: 32246217
Thorax. 2018 Dec;73(12):1177-1181
pubmed: 29666219
Ann Oncol. 2013 Mar;24(3):843-50
pubmed: 23149571
BMC Cancer. 2017 Aug 30;17(1):596
pubmed: 28854969
Environ Res. 2019 May;172:713-718
pubmed: 30903971
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Transl Lung Cancer Res. 2019 Aug;8(4):461-475
pubmed: 31555519
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Int J Cancer. 2020 May 1;146(9):2376-2382
pubmed: 31583690
Ann Thorac Surg. 2004 Jul;78(1):209-15; discussion 215
pubmed: 15223430
Cancer Epidemiol. 2020 Aug;67:101737
pubmed: 32450544